Please assess the completion status of the following clinical trial:

Trial Title: Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* normal weight women with Polycystic ovary syndrome, diagnosed in accordance with Rotterdam Consensus Conference Criteria 2003.~Exclusion Criteria:~* pregnancy~* past history of cardiovascular disease, diabetes mellitus (or impaired glucose tolerance as determined by a standard 75 g oral glucose tolerance test), hypertension~* significant liver or renal impairment~* other hormonal dysfunction (hypothalamic, pituitary, thyroidal or adrenal causes for the clinical signs)~* neoplasms~* unstable mental illness

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- 3 mg drospirenone and 20 µg ethinyl-estradiol (Type: ACTIVE_COMPARATOR): None
- 3 mg drospirenone and 30 µg ethinyl-estradiol (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).